We stand at the threshold of a new era for pharmaceutical supply chains, driven by breakthroughs in personalised medicine, the rising prevalence of biologics, and the integration of digital
Supply chain disruptions are taking centre stage in the media landscape at the outset of 2024, with incidents ranging from blockages in the Panama and Suez Canals to escalating geopolitical
Artificial intelligence (AI) stands at the forefront of technological innovation, reshaping industries on a global scale, with transformation of the specialty healthcare logistics landscape
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
